岭南现代临床外科2016，Vol.16Issue(5)：511-516,6.DOI:10.3969/j.issn.1009-976X.2016.05.001
fMRI（磁共振功能成像）对乳腺癌新辅助化疗评估的研究进展
The progress of current magnetic resonance imaging methods for predicting the response of breast cancer to neoadjuvant chemotherapy
摘要
Abstract
Reliable early assessment of breast cancer response to neoadjuvant therapy (NACT) would provide many benefits to personalize patient care , so the demand for accurate and noninvasive response biomarkers is increasing. Recently, MRI can assess the response according to the morphology changes, like tumor size, enhancement, et al. And now there are increasing numbers of promising MRI technology reflecting the change of tumor in micro-molecular level after neoadjuvant chemotherapy. These MRI technology includes DCE-MRI, MRS, DWI, IVIM. This review focuses on the role of MRI in predicting the efficacy of neoadjuvant chemotherapy for breast cancer.关键词
乳腺癌/磁共振成像/新辅助化疗Key words
Breast cancer/Magnetic resonance imaging/Neoadjuvant chemotherapy分类
医药卫生引用本文复制引用
张梦迪,陈建宇,龚舒,李永,郑桂芬..fMRI（磁共振功能成像）对乳腺癌新辅助化疗评估的研究进展[J].岭南现代临床外科,2016,16(5):511-516,6.基金项目
广东省科技计划项目 （）
